Evaluation of IL-1 beta and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients-MedSci.cn

Evaluation of IL-1 beta and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients

Kianfar, R; Ravanshad, M; Ghiass, MA; Rafiee, N; Shayeghpour, A; Maleki, A

Ravanshad, M (通讯作者)，Tarbiat Modares Univ, Dept Med Virol, Tehran, Iran.

INTERVIROLOGY, 2022; 65 (3): 144

科室
- - 订阅+
  - 更多科室
工具
服务